Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 18Unknown 3Withdrawn 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Sarcoma 7Osteosarcoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Testicular Neoplasms 4Burkitt Lymphoma 4Testicular Germ Cell Tumor 3Teratoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Lymphoma, B-Cell 3Carcinoma, Renal Cell 3Breast Neoplasms 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Ovarian Neoplasms 2Optic Nerve Glioma 2Neuroblastoma 2Neoplasms 2Medulloblastoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphatic Diseases 2Liver Neoplasms 2Kidney Neoplasms 2Immunoproliferative Disorders 2Hematologic Diseases 2Fibrosarcoma 2Familial ependymoma 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Cyclophosphamide 24Mycophenolic Acid 15fludarabine phosphate 14fludarabine 13Whole-Body Irradiation 13Tacrolimus 12Rituximab 12Melphalan 12Filgrastim 11Cyclosporine 11Busulfan 11Radiotherapy 10Peripheral Blood Stem Cell Transplantation 10Antilymphocyte Serum 10Methotrexate 9Doxorubicin 9Gemcitabine 8Etoposide 8Brentuximab Vedotin 8Sirolimus 7pembrolizumab 6Vinblastine 6Nivolumab 6Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Alemtuzumab 6Dacarbazine 5Cytarabine 5Cord Blood Stem Cell Transplantation 5Carmustine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hodgkin Disease × Ifosfamide × Clear all
NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated
442 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡